Difficulty: Medium
Average Score: 66%
Practice
Which analysis of maternal serum is the best predictor of chromosomal abnormalities in the fetus?
Correct answer
B
Rationale
In the context of maternal monitoring for chromosomal abnormalities in the fetus, the best predictor among the provided options is multiple-marker screening (Option B). Multiple-marker screening involves analyzing maternal serum for specific markers that can indicate an increased risk of chromosomal abnormalities such as Down syndrome. This screening test assesses markers like alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol, and inhibin-A.
The rationale behind why multiple-marker screening is the best predictor lies in its ability to detect subtle changes in these markers that may indicate an increased risk of chromosomal abnormalities. This test provides a non-invasive way to assess the fetus's risk without directly sampling fetal genetic material.
Regarding the other options:
A) Biophysical profile: This is a prenatal ultrasound evaluation of fetal well-being and does not directly assess chromosomal abnormalities in the fetus.
C) Lecithin-to-sphingomyelin ratio: This test is used to assess fetal lung maturity and is not specific to predicting chromosomal abnormalities.
D) Blood type and crossmatch of maternal and fetal serum: This is important for assessing blood compatibility but does not directly predict chromosomal abnormalities.
In an educational context, understanding the rationale behind selecting the appropriate screening test for chromosomal abnormalities is crucial for healthcare providers involved in prenatal care. It highlights the importance of selecting the right diagnostic tools to provide accurate information to expectant parents and guide further management and decision-making. By grasping the principles behind these screening tests, healthcare professionals can offer comprehensive care and support to pregnant individuals and their families.
The rationale behind why multiple-marker screening is the best predictor lies in its ability to detect subtle changes in these markers that may indicate an increased risk of chromosomal abnormalities. This test provides a non-invasive way to assess the fetus's risk without directly sampling fetal genetic material.
Regarding the other options:
A) Biophysical profile: This is a prenatal ultrasound evaluation of fetal well-being and does not directly assess chromosomal abnormalities in the fetus.
C) Lecithin-to-sphingomyelin ratio: This test is used to assess fetal lung maturity and is not specific to predicting chromosomal abnormalities.
D) Blood type and crossmatch of maternal and fetal serum: This is important for assessing blood compatibility but does not directly predict chromosomal abnormalities.
In an educational context, understanding the rationale behind selecting the appropriate screening test for chromosomal abnormalities is crucial for healthcare providers involved in prenatal care. It highlights the importance of selecting the right diagnostic tools to provide accurate information to expectant parents and guide further management and decision-making. By grasping the principles behind these screening tests, healthcare professionals can offer comprehensive care and support to pregnant individuals and their families.